“Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost” has been added to your cart. View cart Showing 17–17 of 17 results Default sorting Sort by popularity Sort by latest Sort by price: low to high Sort by price: high to low What’s new in perimetry? €15.00 Add to cart ← 1 2